Amgen Inc (AMGN)
270.05
+0.67
(+0.25%)
USD |
NASDAQ |
Apr 26, 16:00
270.05
0.00 (0.00%)
After-Hours: 17:25
Amgen Shares Outstanding: 535.92M for Feb. 9, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
February 09, 2024 | 535.92M |
December 31, 2023 | 535.40M |
October 26, 2023 | 535.18M |
September 30, 2023 | 535.10M |
July 31, 2023 | 534.90M |
June 30, 2023 | 534.90M |
April 24, 2023 | 534.33M |
March 31, 2023 | 534.30M |
March 20, 2023 | 534.22M |
February 06, 2023 | 533.98M |
December 31, 2022 | 534.00M |
October 31, 2022 | 533.58M |
September 30, 2022 | 533.50M |
August 01, 2022 | 534.93M |
June 30, 2022 | 534.90M |
April 22, 2022 | 534.20M |
March 31, 2022 | 534.20M |
March 18, 2022 | 533.78M |
February 25, 2022 | 533.77M |
February 11, 2022 | 557.03M |
December 31, 2021 | 558.30M |
October 28, 2021 | 563.27M |
September 30, 2021 | 565.00M |
July 29, 2021 | 567.85M |
June 30, 2021 | 569.60M |
Date | Value |
---|---|
April 22, 2021 | 574.55M |
March 31, 2021 | 575.30M |
March 19, 2021 | 575.80M |
February 03, 2021 | 577.57M |
December 31, 2020 | 578.30M |
October 23, 2020 | 582.17M |
September 30, 2020 | 583.50M |
July 23, 2020 | 585.69M |
June 30, 2020 | 586.40M |
April 27, 2020 | 588.25M |
March 31, 2020 | 588.00M |
March 20, 2020 | 587.76M |
February 06, 2020 | 589.81M |
December 31, 2019 | 591.40M |
October 23, 2019 | 594.18M |
September 30, 2019 | 596.20M |
July 24, 2019 | 599.70M |
June 30, 2019 | 602.10M |
April 24, 2019 | 609.94M |
March 31, 2019 | 614.40M |
March 22, 2019 | 615.95M |
February 07, 2019 | 622.28M |
December 31, 2018 | 629.60M |
October 24, 2018 | 637.22M |
September 30, 2018 | 640.50M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
533.50M
Minimum
Sep 30 2022
602.10M
Maximum
Jun 30 2019
560.30M
Average
563.27M
Median
Oct 28 2021
Shares Outstanding Benchmarks
Gilead Sciences Inc | 1.246B |
Johnson & Johnson | 2.410B |
Eli Lilly and Co | 950.77M |
Merck & Co Inc | 2.533B |
Vertex Pharmaceuticals Inc | 258.31M |